Long COVID or post-COVID-19 syndrome first gained widespread recognition among social support groups and later in scientific and medical communities. This illness is poorly understood as it affects COVID-19 survivors at all levels of disease severity, even younger adults, children, and those not hospitalized. While the precise definition of long COVID may be lacking, the…
Infectious Diseases Template
Write in a clean editor, then format for Infectious Diseases in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Infectious Diseases format
Infectious Diseases is a peer-reviewed journal published by Taylor & Francis, covering Antibiotic Resistance in Bacteria, COVID-19 Clinical Research Studies, Antimicrobial Resistance in Staphylococcus.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Infectious Diseases 12 (3): 45–58.
Formats any DOI in Infectious Diseases style. No sign-up. |
| Publishes research in | Antibiotic Resistance in Bacteria COVID-19 Clinical Research Studies Antimicrobial Resistance in Staphylococcus Bacterial Identification and Susceptibility Testing Tuberculosis Research and Epidemiology |
| ISSN | 2374-4235 |
| Citation impact (2-yr) | 2.61 |
| h-index | 53 |
| i10-index | 671 |
| Total citations | 22,990 |
| Top institutions publishing here | Karolinska Institutet |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Infectious Diseases per year
Citation impact of Infectious Diseases by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Infectious Diseases
When a newborn presents with non-specific symptoms of infection with an added history of COVID-19 in his/her parents, it indicates the need for PCR testing for Novel coronavirus.
BACKGROUND: Knowledge on bacterial co-infections in COVID-19 is crucial to use antibiotics appropriately. Therefore, we aimed to determine the incidence of bacterial co-infections, antibiotic use and application of antimicrobial stewardship principles in hospitalized patients with COVID-19. METHODS: We performed a retrospective observational study in four hospitals (1 university, 2 non-university teaching, 1 non-teaching hospital) in…
BACKGROUND: There is a growing literature on the association of SARS-CoV-2 and other chronic conditions, such as noncommunicable diseases. However, little is known about the impact of coinfection with tuberculosis. We aimed to compare the risk of death and recovery, as well as time-to-death and time-to-recovery, in COVID-19 patients with and without tuberculosis. METHODS: We…
PURPOSE: To review the epidemiology of Staphylococcus aureus bacteraemia (SAB) and endocarditis (SAE), and discuss the short- and long-term outcome. Materials and methods: A literature review of the epidemiology of SAB and SAE. RESULTS: The reported incidence of SAB in Western countries is 16-41/100,000 person-years. Increasing incidence has been observed in many regions, in Iceland…